Literature DB >> 21667071

Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Francesco Violi1, Gregory Y H Lip, Stefania Basili.   

Abstract

Atrial fibrillation (AF) is commonly associated with a significant increase in stroke and thromboembolic risk. Many patients with AF have associated atherothrombosis given the many risk factors for atherosclerosis that also predispose to AF. Vascular disease, whether peripheral artery disease or myocardial infarction, contributes to the increased risk of stroke and thromboembolism, and has been included in stroke risk assessment schema. This review analyzes the interplay between AF and peripheral artery disease in relation to their associated pathophysiology, as well as epidemiological data linking both conditions and the associated thromboembolic complications conferred by the presence of both.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667071     DOI: 10.1007/s11739-011-0637-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  46 in total

1.  The ankle-brachial index as a biomarker of cardiovascular risk: it's not just about the legs.

Authors:  Todd S Perlstein; Mark A Creager
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

2.  The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue.

Authors:  Licia Polimeni; Ludovica Perri; Mirella Saliola; Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2010-03-03       Impact factor: 3.397

3.  High coronary artery calcium scores pose an extremely elevated risk for hard events.

Authors:  Roberto Wayhs; Allan Zelinger; Paolo Raggi
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

4.  Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.

Authors:  F L Li-Saw-Hee; A D Blann; D Gurney; G Y Lip
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

5.  Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.

Authors:  Bethan Freestone; Aun Yeong Chong; Sarah Nuttall; Gregory Y H Lip
Journal:  Thromb Res       Date:  2007-11-08       Impact factor: 3.944

6.  Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.

Authors:  Joseph G Akar; Walter Jeske; David J Wilber
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

7.  Prognostic value of extensive coronary calcium quantities in symptomatic males--a 5-year follow-up study.

Authors:  Stefan Möhlenkamp; Nils Lehmann; Axel Schmermund; Heiko Pump; Susanne Moebus; Dietrich Baumgart; Rainer Seibel; Dietrich H W Grönemeyer; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

Review 8.  Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.

Authors:  Michael Hughes; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

9.  Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.

Authors:  Domenico Ferro; Lorenzo Loffredo; Licia Polimeni; Filippo Fimognari; Paolo Villari; Pasquale Pignatelli; Valentin Fuster; Francesco Violi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-27       Impact factor: 8.311

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  9 in total

1.  CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project.

Authors:  Angela Sciacqua; Maria Perticone; Giovanni Tripepi; Eliezer J Tassone; Antonio Cimellaro; Deborah Mazzaferro; Giorgio Sesti; Francesco Perticone
Journal:  Intern Emerg Med       Date:  2015-05-05       Impact factor: 3.397

Review 2.  Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation.

Authors:  Valentina Arnao; Giancarlo Agnelli; Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2015-04-11       Impact factor: 3.397

3.  Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.

Authors:  Valeria Raparelli; Marco Proietti; Carmelo Buttà; Paolo Di Giosia; Domenico Sirico; Paolo Gobbi; Salvatore Corrao; Giovanni Davì; Anna Rita Vestri; Francesco Perticone; Gino Roberto Corazza; Francesco Violi; Stefania Basili
Journal:  Intern Emerg Med       Date:  2014-07-03       Impact factor: 3.397

Review 4.  Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation.

Authors:  Francesco Violi; Daniele Pastori; Pasquale Pignatelli
Journal:  J Atr Fibrillation       Date:  2014-10-31

5.  Atrial Fibrillation Predicts Cardiovascular Outcome in Hypertensive Patients With Symptomatic Peripheral Artery Disease and Preserved Ejection Fraction.

Authors:  Mislav Vrsalovic; Ksenija Vucur; Bojan Jelakovic
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-14       Impact factor: 3.738

Review 6.  Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.

Authors:  Giovanni Di Minno; Gaia Spadarella; Giovanni Cafaro; Maurizio Petitto; Roberta Lupoli; Alessandro Di Minno; Giovanni de Gaetano; Elena Tremoli
Journal:  Ann Med       Date:  2014-07-21       Impact factor: 4.709

7.  Subclinical Measures of Peripheral Atherosclerosis and the Risk of New-Onset Atrial Fibrillation in the General Population: the Rotterdam Study.

Authors:  Sven Geurts; Cathrine Brunborg; Grigorios Papageorgiou; M Arfan Ikram; Maryam Kavousi
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 5.501

8.  Atrial Fibrillation Increases the Risk of Peripheral Arterial Disease With Relative Complications and Mortality: A Population-Based Cohort Study.

Authors:  Chia-Jung Chang; Yen-Ting Chen; Chiu-Shong Liu; Wen-Yuan Lin; Cheng-Li Lin; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Atrial Fibrillation is Associated with Femoropopliteal Totally Occlusive In-Stent Restenosis: A Single-Center, Retrospective, Observational Study.

Authors:  Yohsuke Honda; Keisuke Hirano; Masahiro Yamawaki; Motoharu Araki; Norihiro Kobayashi; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Kenji Makino; Shigemitsu Shirai; Masafumi Mizusawa; Takahiro Nakano; Yoshiaki Ito
Journal:  J Interv Cardiol       Date:  2021-02-03       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.